Email Us

Individualized Medication Guidance for Breast Cancer CapitalBio

This test detects 348 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for breast cancer patients.

individualized medication guidance for breast cancer

Features of Individualized Medication Guidance for Breast Cancer

Features of Individualized Medication Guidance for Breast Cancer

Applicable Population of Individualized Medication Guidance for Breast Cancer

  • Late-stage newly diagnosed breast cancer patients who need targeted therapy and immunotherapy.

  • Patients with relapsed, drug-resistant breast cancer.

  • Breast cancer patients who need targeted therapy and immunotherapy through liquid biopsy.

Products
Contact with Capitalbio
Contact Information
Your Inquiries (Expandable)
Instruments
Detection Kits/Reagents
Research Services
Biochip Design & Fabrication
Diagnostic Services
86-10-69002900
Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing